Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate (original) (raw)

• Lehner, T. et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258, 1365–1369 (1992).
  Article CAS Google Scholar
• Lehner, T. et al. T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc. natn. Acad. Sci. U.SA. 90, 8638–8642 (1993).
  Article CAS Google Scholar
• Lehner, T. et al. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J. Virol 68, 1624–1632 (1994).
  CAS PubMed PubMed Central Google Scholar
• Burnett, P.R., VanCott, T.C., Polonis, V.R., Redfield, R.R. & Birx, D.L., IgA-mediated neutralization of HIV type 1. J. Immun. 152, 4642–4648 (1994).
  CAS PubMed Google Scholar
• Okuda, K. et al. Strong immunogenicity of a multicomponent peptide vaccine developed with the branched lysine oligopeptide method for human immunodeficiency virus infection. J. Molec. Recognition 6, 101–109 (1993).
  Article CAS Google Scholar
• Okuda, K. et al. Strong synergistic effects of multicomponent vaccine for human immunodeficiency virus infection. J. clin. lab. Immun. 40, 97–113 (1993).
  CAS Google Scholar
• Rockson, R.J. et al. Optimizing oral vaccines: Induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect Immun. 61, 4272–4279 (1993).
  Google Scholar
• Xu-Amano, J. et al. Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. exp. Med. 178, 1309–1320 (1993).
  Article CAS Google Scholar
• Lycke, N. & Holmgren, J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59, 301–308 (1986).
  CAS PubMed PubMed Central Google Scholar
• Inami, S. et al. Serum antibody directed against synthetic peptides derived from HIV-1 protein sequence obtained from 26 Japanese HIV-1-infected individuals. AIDS 5, 1140–1141 (1991).
  Article CAS Google Scholar
• Okuda, K. et al. A serogic analysis and the amino acid sequence of the V3 region of human immunodeficiency virus from carriers in Bangkok. J. infect. Dis. 169, 227–228 (1994).
  Article CAS Google Scholar
• Ubolyam, S., Ruxrungtham SirMchayakul, S., Okuda, K. & Phanuphak, P. Evidence of three HIV-1 subtypes in subgroups of individuals in Thailand. Lancet 344, 485–486 (1994).
  Article CAS Google Scholar
• Bukawa, H. et al. Antibody responses raised against a conformational V3 loop peptide of HIV-1. Micorbiol Immun. (in the press).
• McKeating, J.A., Cordell, J., Dean, C.J. & Balfe, P. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120. Virology 191, 732–742 (1992).
  Article CAS Google Scholar
• Achour, A. et al. HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc. natn. Acad. Sci. U.S.A. 87, 7045–049 (1990).
  Article CAS Google Scholar
• Boucher, C.A.B. et al. Immune response and epitope mapping of a candidate HIV-1 pl7 vaccine HGP30. J. clin. Lab. Anal. 4, 43–47 (1990).
  Article CAS Google Scholar
• Nardelli, B. et al. A chemically defined synthetic vaccine model for HIV-1. J. Immun. 148, 914–920 (1992).
  CAS PubMed Google Scholar
• Defoort, J.-P., Nardelli, B., Huang, W., Ho, D.D. & Tam, J.P. Macromolecular assemblage in the design of a synthetic AIDS vaccine. Proc. natn. Acad. Sci. U.S.A. 89, 3879–3883 (1992).
  Article CAS Google Scholar
• Korn, A.H., Feairheller, S.H. & Filachione, E.M., Nature of the reagent. J. molec. Biol 65, 525–529 (1972).
  Article CAS Google Scholar
• Reichlin, M. Use of glutaraldehyde as a coupling agent for proteins and peptides. Meth. Enzym. 70, 159–165 (1980).
  Article CAS Google Scholar
• Staats, H.F. et al. Mucosal immunity to infection with implications for vaccine development. Curr. Opin. Immun. 6, 572–583 (1994).
  Article CAS Google Scholar
• Bourguin, I., Chardes, T. & Bout, D. Oral immunization with _Toxoplasma gondii_antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57/BL/6 mice. Infect. Immun. 61, 2082–2088 (1993).
  CAS PubMed PubMed Central Google Scholar
• Nara, P.L. et al. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. hum. Retrovir. 3, 283–302 (1987).
  Article CAS Google Scholar
• Putney, S.D. et al. HTLV-III/LAV-neutralizing antibodies to an _E. coli_-produced fragment of the virus envelope. Science 234, 1392–1395 (1986).
  Article CAS Google Scholar
• Pauwels, R. et al. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. virol. Meth. 20, 309–321 (1988).
  Article CAS Google Scholar
• Nakashima, H. Development of anti-human immunodeficiency virus (HIV) agents. Bull. Yamaguchi Med. Sch. 37, 169–180 (1990).
  CAS Google Scholar
• Lai, P.K. et al. Modification of human immunodeficiency viral replication by pine cone extracts. AIDS Res. hum. Retrovir. 6, 205–217 (1990).
  Article CAS Google Scholar
• Goudsmit, J. et al. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 2, 177–180(1986).
  Article Google Scholar
• Okuda, K., Minami, M., Ju, S.-T. & Dorf, M.E. Functional association of idio-typic and I-J determinants on the antigen receptor of suppressor T cells. Proc. natn. Acad. Sci. U.SA. 78, 4557–4561 (1981).
  Article CAS Google Scholar
• Lehner, T. et al. A comparison of the immune responses following oral, vaginal, or rectal route of immunization with SIV antigens in nonhuman primates. Vaccine Res. 1, 319–330 (1992).
  Google Scholar
• Kaartinen, M., Imir, T., Klockars, M., Sandholm, M. & Mäkelä, O. IgA in blood and thoracic duct lymph: Concentration and degree of polymerization. Scand. J. Immun. 7, 229–232 (1978).
  Article CAS Google Scholar
• Olson, C.A., Williams, L.C., McLaughlin-Taylor, E. & McMillan, M. Creation of H-2 class I epitopes using synthetic peptides: Recognition by alloreactive cytotoxic T lymphocytes. Proc. natn. Acad. Sci. U.SA. 86, 1031–1035 (1989).
  Article CAS Google Scholar
• deVos, T. & Dick, T.A. A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin. J. immunoh Meth. 141, 285–288 (1991).
  Article CAS Google Scholar